Global Urinalysis Test Market Research Report—Forecast till 2025

$4,450$6,250

Clear
SKU: 200043 Category: Tag:

Description

Global Urinalysis Test Market: Information by Product Type (Consumables and Instruments), By Test Type (Sediment Analysis and Biochemical Analysis), By Application (Disease Diagnosis and Pregnancy & Fertility), By End User (Hospitals and Clinics, Diagnostic Laboratories and Home Care Settings) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2025

Market analysis
Generally, Urinalysis testing involves a series of tests for the diagnosis of common diseases. The sample may be observed for color, cloudiness, concentration, signs of drug use, and chemical composition, including glucose, the presence of protein, blood cells, or germ, or other signs of disease. These diseases are inclusive of urinary tract infections, kidney disorders, diabetes, and other problems. Urinalysis refers to the analysis of urine samples for diagnosis in pathological laboratories. Other features such as the rising prevalence of diabetes, rising incidence of kidney diseases, a mounting number of research organizations and associations for diabetes, increasing geriatric population, and the influence of sedentary lifestyle and unhealthy diet are pouring the urinalysis test market. However, factors such as limited indications of urinalysis tests and stringent reimbursement policies in developing countries are hampering the growth of the market. Also, the increasing number of research organizations creating awareness about various diagnostic tests for diabetes is projected to drive the growth of the market. The increasing occurrences of chronic kidney diseases (CKD) and diabetes globally, coupled with the upcoming activities by key players such as product launches and approvals, are projected to positively impact to the growth of the global urinalysis test market.

Market segmentation
The Global Urinalysis Test Market is segmented into product type, test type, application and end user respectively. Based on the test type, the urinalysis test market has been categorized as pregnancy and fertility tests, biochemical analysis, and sediment analysis. The sediment analysis segment is likely to hold a substantial market share during the next seven years owing to the rising adoption of urinary sediment examination to precisely classify and measure urine machineries, such as epithelial cells, non-epithelial cells (blood cells), salts or crystals, casts, and microorganisms. Based on product type, the urinalysis test market has been classified as consumables and devices. The consumables segment has been further apportioned into pregnancy & fertility kits, dipsticks, disposables, and reagents. The consumables segment is expected to command the market over the review period owing to the repetitive use of consumables during urinalysis practices. By end user, the global urinalysis test market has been segmented into hospitals and clinics, diagnostic laboratories, home care settings, and others. The hospitals and clinics sector would lead the market throughout the forecast period since urine analysis has become a part of the general checkup in hospitals and clinics as well as a high number of urinalysis procedures are associated with these healthcare facilities. On the basis of application, the global urinalysis test market has been segregated into disease diagnosis, pregnancy and fertility, and others. The disease diagnosis segment spearheaded the market in 2018 attributed to facts such as the rising prevalence of urinary tract infections, diabetes, and kidney diseases along with rising implementation of urinalysis tests, and the overview of technologically progressive, rapid, non-invasive, and user-friendly tools for urinalysis.

Regional analysis
Geographically the Global Urinalysis Test Market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The Americas was the largest market for urinalysis tests in 2018 due to the rising demand for automated urine analyzers, technological advancements in urinalysis test instruments, and rising incidence of kidney and liver diseases in the US and Canada. In North America, the US held the largest share of the market in 2018 owing to the presence of significant players focused on producing urine analyzers and consumables, rising research actions in the field of urinalysis, and growing awareness about customized medications.

Major players
The proposed spectators in the Global Urinalysis Test Market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Urinalysis Test Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Urinalysis Test Market are companies like Bio-Rad Laboratories (US), Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US), URIT Medical Electronic Ltd (China) and Arkray Inc. (Japan).

Table of Contents

TABLE OF CONTENTS
1  Executive Summary
1.1 MARKET SYNOPSIS 22

1.2 MARKET ATTRACTIVENESS ANALYSIS 23

1.3 GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE 24

1.4 GLOBAL URINALYSIS TEST MARKET, BY TEST TYPE 25

1.5 GLOBAL URINALYSIS TEST MARKET, BY APPLICATION 26

1.6 GLOBAL URINALYSIS TEST MARKET, BY END USER 27

2  Market Introduction
2.1 DEFINITION 28

2.2 SCOPE OF THE STUDY 28

2.3 RESEARCH OBJECTIVE 28

2.4 MARKET STRUCTURE 28

2.5 ASSUMPTIONS & LIMITATIONS 29

3  Research Methodology
3.1 DATA MINING 30

3.2 SECONDARY RESEARCH 31

3.3 PRIMARY RESEARCH 32

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 33

3.5 FORECASTING TECHNIQUES 34

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 35

3.6.1 BOTTOM-UP APPROACH 36

3.6.2 TOP-DOWN APPROACH 36

3.7 DATA TRIANGULATION 37

3.8 VALIDATION 37

4  MARKET DYNAMICS
4.1 OVERVIEW 38

4.2 DRIVERS 39

4.2.1 RISING PREVALENCE OF DIABETES 39

4.2.2 RISING PREVALENCE OF KIDNEY DISEASES 39

4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 39

4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 40

4.3 RESTRAINTS 41

4.3.1 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 41

4.3.2 SUPPLY OF DEFECTIVE AND FAULTY PRODUCTS 41

4.4 OPPORTUNITIES 42

4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES 42

4.4.2 EXPANSION IN DEVELOPING ECONOMIES 42

5  MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 43

5.1.1 THREAT OF NEW ENTRANTS 43

5.1.2 BARGAINING POWER OF SUPPLIERS 44

5.1.3 THREAT OF SUBSTITUTES 44

5.1.4 BARGAINING POWER OF BUYERS 44

5.1.5 INTENSITY OF RIVALRY 44

5.2 VALUE CHAIN ANALYSIS 45

5.2.1 R&D AND DESIGNING 45

5.2.2 MANUFACTURING 45

5.2.3 DISTRIBUTION 46

5.2.4 MARKETING & SALES 46

5.2.5 POST-SALES MONITORING 46

6  GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 47

6.2 CONSUMABLES 48

6.2.1 PREGNANCY & FERTILITY KITSC 49

6.2.2 DIPSTICKS 50

6.2.3 DISPOSABLES REAGENTS 50

6.2.4 REAGENTS 51

6.3 INSTRUMENTS 51

6.3.1 AUTOMATED URINE ANALYZERS 52

6.3.2 SEMI-AUTOMATED URINE ANALYZERS 56

6.3.3 POINT-OF-CARE URINE ANALYZERS 57

7  GLOBAL URINALYSIS TEST MARKET, TEST TYPE
7.1 OVERVIEW 58

7.2 SEDIMENT ANALYSIS 59

7.3 BIOCHEMICAL ANALYSIS 60

7.3.1 LABORATORY TESTS 61

7.3.2 POINT-OF-CARE TESTS 61

7.4 PREGNANCY AND FERTILITY TESTS 62

8  GLOBAL URINALYSIS TEST MARKET, APPLICATION
8.1 OVERVIEW 63

8.2 DISEASE DIAGNOSIS 64

8.2.1 KIDNEY DISEASES 65

8.2.2 DIABETES 66

8.2.3 URINARY TRACT INFECTIONS 67

8.3 PREGNANCY & FERTILITY 68

9  GLOBAL URINALYSIS TEST MARKET, END USER
9.1 OVERVIEW 69

9.2 HOSPITALS AND CLINICS 70

9.3 DIAGNOSTIC LABORATORIES 71

9.4 HOME CARE SETTINGS 72

9.5 OTHERS 72

10  GLOBAL URINALYSIS TEST MARKET, BY REGION
10.1 OVERVIEW 73

10.2 AMERICAS 75

10.2.1 NORTH AMERICA 80

10.2.2 LATIN AMERICA 93

10.3 EUROPE 98

10.3.1 WESTERN EUROPE 103

10.3.2 EASTERN EUROPE 134

10.4 ASIA-PACIFIC 139

10.4.1 CHINA 144

10.4.2 JAPAN 148

10.4.3 INDIA 152

10.4.4 AUSTRALIA 157

10.4.5 SOUTH KOREA 161

10.4.6 REST OF ASIA-PACIFIC 165

10.5 MIDDLE EAST & AFRICA 170

10.5.1 MIDDLE EAST 175

10.5.2 AFRICA 179

11  COMPETITIVE LANDSCAPE
11.1 OVERVIEW 183

11.2 COMPETITIVE BENCHMARKING 184

11.3 GLOBAL URINALYSIS TEST MARKET, COMPANY SHARE ANALYSIS, 2018 186

11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL URINALYSIS TEST MARKET 186

11.5 KEY DEVELOPMENT ANALYSIS 187

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 187

11.6.1 CONTRACTS & AGREEMENTS 187

11.6.2 MERGER & ACQUISITION 188

11.6.3 NEW PRODUCT LAUNCH 188

11.6.4 EXPANSIONS 188

11.6.5 APPROVALS 189

12  COMPANY PROFILES
12.1 ABBOTT LABORATORIES 190

12.1.1 COMPANY OVERVIEW 190

12.1.2 FINANCIAL OVERVIEW 190

12.1.3 PRODUCTS/SERVICES OFFERED 191

12.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS 191

12.1.5 SWOT ANALYSIS 191

12.1.6 KEY STRATEGIES 191

12.2 BIO-RAD LABORATORIES, INC. 192

12.2.1 COMPANY OVERVIEW 192

12.2.2 FINANCIAL OVERVIEW 192

12.2.3 PRODUCTS/SERVICES OFFERED 193

12.2.4 KEY DEVELOPMENTS 193

12.2.5 SWOT ANALYSIS 193

12.2.6 KEY STRATEGIES 194

12.3 BECKMAN COULTER INC. 195

12.3.1 COMPANY OVERVIEW 195

12.3.2 FINANCIAL OVERVIEW 195

12.3.3 PRODUCTS/SERVICES OFFERED 196

12.3.4 KEY DEVELOPMENTS 196

12.3.5 SWOT ANALYSIS 196

12.3.6 KEY STRATEGIES 197

12.4 F. HOFFMANN-LA ROCHE LTD 198

12.4.1 COMPANY OVERVIEW 198

12.4.2 FINANCIAL OVERVIEW 198

12.4.3 PRODUCTS/SERVICES OFFERED 199

12.4.4 KEY DEVELOPMENTS 199

12.4.5 SWOT ANALYSIS 199

12.4.6 KEY STRATEGIES 199

12.5 SIEMENS HEALTHINEERS 200

12.5.1 COMPANY OVERVIEW 200

12.5.2 FINANCIAL OVERVIEW 200

12.5.3 PRODUCTS/SERVICES OFFERED 201

12.5.4 KEY DEVELOPMENTS 201

12.5.5 SWOT ANALYSIS 202

12.5.6 KEY STRATEGIES 202

12.6 EKF DIAGNOSTICS 203

12.6.1 COMPANY OVERVIEW 203

12.6.2 FINANCIAL OVERVIEW 203

12.6.3 PRODUCTS/SERVICES OFFERED 204

12.6.4 KEY DEVELOPMENTS 204

12.6.5 SWOT ANALYSIS 204

12.6.6 KEY STRATEGIES 205

12.7 ARKRAY, INC. 206

12.7.1 COMPANY OVERVIEW 206

12.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW 206

12.7.3 PRODUCTS/SERVICES OFFERED 206

12.7.4 KEY DEVELOPMENTS 206

12.7.5 SWOT ANALYSIS 207

12.7.6 KEY STRATEGIES 207

12.8 TRINITY BIOTECH PLC 208

12.8.1 COMPANY OVERVIEW 208

12.8.2 FINANCIAL OVERVIEW 208

12.8.3 PRODUCTS/SERVICES OFFERED 209

12.8.4 KEY DEVELOPMENTS 209

12.8.5 SWOT ANALYSIS 209

12.8.6 KEY STRATEGIES 209

12.9 ANALYTICON BIOTECHNOLOGIES AG 210

12.9.1 COMPANY OVERVIEW 210

12.9.2 FINANCIAL OVERVIEW 210

12.9.3 PRODUCTS/SERVICES OFFERED 210

12.9.4 KEY DEVELOPMENTS 210

12.9.5 SWOT ANALYSIS 211

12.9.6 KEY STRATEGIES 211

12.10 77 ELEKTRONIKA KFT. 212

12.10.1 COMPANY OVERVIEW 212

12.10.2 FINANCIAL OVERVIEW 212

12.10.3 PRODUCTS/SERVICES OFFERED 212

12.10.4 KEY DEVELOPMENTS 212

12.10.5 SWOT ANALYS 213

12.10.6 KEY STRATEGIES 213

12.11 YD DIAGNOSTICS 214

12.11.1 COMPANY OVERVIEW 214

12.11.2 FINANCIAL OVERVIEW 214

12.11.3 PRODUCTS/SERVICES OFFERED 214

12.11.4 KEY DEVELOPMENTS 214

12.11.5 SWOT ANALYSIS 215

12.11.6 KEY STRATEGIES 215

12.12 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD 216

12.12.1 COMPANY OVERVIEW 216

12.12.2 FINANCIAL OVERVIEW 216

12.12.3 PRODUCTS/SERVICES OFFERED 216

12.12.4 KEY DEVELOPMENTS 216

12.12.5 SWOT ANALYS 217

12.12.6 KEY STRATEGIES 217

12.13 ERBA MANNHEIM 218

12.13.1 COMPANY OVERVIEW 218

12.13.2 FINANCIAL OVERVIEW 218

12.13.3 PRODUCTS/SERVICES OFFERED 218

12.13.4 KEY DEVELOPMENTS 218

12.13.5 SWOT ANALYS 219

12.13.6 KEY STRATEGIES 219

12.14 CARDINAL HEALTH 220

12.14.1 COMPANY OVERVIEW 220

12.14.2 FINANCIAL OVERVIEW 220

12.14.3 PRODUCTS/SERVICES OFFERED 221

12.14.4 KEY DEVELOPMENTS 221

12.14.5 SWOT ANALYSIS 221

12.14.6 KEY STRATEGY 221

12.15 THERMO FISHER SCIENTIFIC INC. 222

12.15.1 COMPANY OVERVIEW 222

12.15.2 FINANCIAL OVERVIEW 222

12.15.3 PRODUCTS/SERVICES OFFERED 223

12.15.4 KEY DEVELOPMENTS 223

12.15.5 SWOT ANALYSIS 223

12.15.6 KEY STRATEGIES 223

12.16 QUIDEL CORPORATION 224

12.16.1 COMPANY OVERVIEW 224

12.16.2 FINANCIAL OVERVIEW 224

12.16.3 PRODUCTS/SERVICES OFFERED 225

12.16.4 KEY DEVELOPMENTS 225

12.16.5 SWOT ANALYSIS 225

12.16.6 KEY STRATEGIES 225

12.17 SYSMEX CORPORATION 226

12.17.1 COMPANY OVERVIEW 226

12.17.2 FINANCIAL OVERVIEW 226

12.17.3 PRODUCTS/SERVICES OFFERED 227

12.17.4 KEY DEVELOPMENTS 227

12.17.5 SWOT ANALYS 227

12.17.6 KEY STRATEGIES 228

12.18 ACON LABORATORIES, INC. 229

12.18.1 COMPANY OVERVIEW 229

12.18.2 FINANCIAL OVERVIEW 229

12.18.3 PRODUCTS/SERVICES OFFERED 229

12.18.4 KEY DEVELOPMENTS 229

12.18.5 SWOT ANALYSIS 230

12.18.6 KEY STRATEGIES 230

12.19 BECTON, DICKINSON AND COMPANY 231

12.19.1 COMPANY OVERVIEW 231

12.19.2 FINANCIAL OVERVIEW 231

12.19.3 PRODUCTS/SERVICES OFFERED 232

12.19.4 KEY DEVELOPMENTS 232

12.19.5 SWOT ANALYS 232

12.19.6 KEY STRATEGIES 232

12.20 URIT MEDICAL ELECTRONIC C0., LTD 233

12.20.1 COMPANY OVERVIEW 233

12.20.2 FINANCIAL OVERVIEW 233

12.20.3 PRODUCTS/SERVICES OFFERED 233

12.20.4 KEY DEVELOPMENTS 233

12.20.5 SWOT ANALYSIS 234

12.20.6 KEY STRATEGIES 234

12.21 DIRUI 235

12.21.1 COMPANY OVERVIEW 235

12.21.2 FINANCIAL OVERVIEW 235

12.21.3 PRODUCTS/SERVICES OFFERED 235

12.21.4 KEY DEVELOPMENTS 235

12.21.5 SWOT ANALYS 236

12.21.6 KEY STRATEGIES 236

13  APPENDIX
13.1 REFERENCES 237

13.2 RELATED REPORTS 237

Additional information

Publisher

Geography Covered

Date Published

Pages

Format